BioShield Funding: Aventis Prefers Production Deals, Not R&D Support
Executive Summary
Aventis-Pasteur would prefer a guaranteed manufacturing agreement rather than incremental payments for bioterrorism countermeasures developed under "Project BioShield.
You may also be interested in...
PhRMA Urges Antitrust Exemption For Bioterrorism Research
An antitrust exemption to allow pharmaceutical companies to share production techniques for bioterrorism countermeasures will speed development of necessary agents, the Pharmaceutical Research & Manufacturers of America says
PhRMA Urges Antitrust Exemption For Bioterrorism Research
An antitrust exemption to allow pharmaceutical companies to share production techniques for bioterrorism countermeasures will speed development of necessary agents, the Pharmaceutical Research & Manufacturers of America says
BioShield Should Extend Liability Protection To Unapproved Products – BIO
Liability protections under "Project BioShield" should be extended to companies that make unapproved bioterrorism countermeasures available in an emergency situation, the Biotechnology Industry Organization said
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: